Quoin Pharmaceuticals (QNRX) Change in Acquisitions & Divestments (2023 - 2026)

Quoin Pharmaceuticals has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at $5.1 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 84.1% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 20.35% YoY) and the FY2025 annual result came in at $8.0 million, down 48.03% from the prior year.
• Change in Acquisitions & Divestments improved to $5.1 million in Q1 2026 per QNRX's latest filing, from $995720.0 in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $10.0 million in Q1 2023 and troughed at $995720.0 in Q4 2025.
• A 4-year average of $3.7 million and a median of $3.0 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments sank 64.69% in 2025, then jumped 84.1% in 2026.
• Over 4 years, Change in Acquisitions & Divestments stood at $2.6 million in 2023, then grew by 6.66% to $2.8 million in 2024, then tumbled by 64.69% to $995720.0 in 2025, then jumped by 412.15% to $5.1 million in 2026.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $5.1 million, $995720.0, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.